Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Clinical Trial of a Selective Estrogen Receptor Modulator (LY353381*HCl) in High Risk Women With Fine Needle Aspiration Cytologic Evidence of Hyperplasia

NCT00005879 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.

NCT NCT00005879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00005879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Clinical Trial of a Selective Estrogen Receptor Modulator (LY353381*HCl) in High Risk Women With Fine Needle Aspiration Cytologic Evidence of Hyperplasia
Lead sponsor
University of Kansas Medical Center
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2000
Completion date
July 31, 2008
Enrollment
199 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer